David Hartnett is the vice president of bioscience-health IT industry development for the Metro Atlanta Chamber (MAC). Hartnett has more than 19 years of senior management experience in medical device, pharmaceutical and Health IT.
Prior to joining MAC, he served as the managing partner of Medical Device Marketing, a privately held professional service consulting and strategic execution company. In that post, he specialized in developing commercialization strategies for small-to mid-cap medical-device companies. His diverse experience has contributed to the success of six premier medical device companies receiving international recognition. He has served as a lead in the management, development and commercialization of more than 14 medical devices.
Prior to Medical Device Marketing, Hartnett served as the president and CEO of United Pharma, a privately
held medical device/pharmaceutical company based in Duluth, GA and headquartered in Lille, France. Prior
to United Pharma, Hartnett was president and CEO of SteriFx Corporation, a specialty chemical company,
contracted by U.S. Department of Defense (DARPA).
Prior to SteriFx, he was the executive vice president of the North American headquarters of Given Imaging, Inc. (NASDAQ: GIVN). Given Imaging rede? ned gastrointestinal diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting gastrointestinal disorders. The company
featured the “PillCam” video capsule, a disposable capsule that captures video after it is ingested by the patient. Hartnett helped to raise more than $30 million in private equity for corporate infrastructure development and product commercialization prior to the company going public in 2001.
Hartnett served as vice president of marketing at ERBE Electrosurgery, the largest manufacturer of
electrosurgical systems in the world, where he was responsible for commercial marketing throughout North
America. He has also served in a variety of other key sales and marketing roles for the following companies: Karl Storz Lithotripsy, Genzyme (formerly Deknatel), STERIS (formerly AMSCO) and the XEROX Corporation.
He holds a B.A. in speech communication from San Diego State University with a master’s equivalent in marketing through post-graduate studies.